These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 6942429)

  • 41. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of terminal differentiation in human K562 erythroleukemia cells by arabinofuranosylcytosine.
    Luisi-DeLuca C; Mitchell T; Spriggs D; Kufe DW
    J Clin Invest; 1984 Sep; 74(3):821-7. PubMed ID: 6590568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA strand breaks caused by inhibitors of DNA synthesis: 1-beta-D-arabinofuranosylcytosine and aphidicolin.
    Fram RJ; Kufe DW
    Cancer Res; 1982 Oct; 42(10):4050-3. PubMed ID: 6809309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of drug sensitivity of human leukaemic myeloblasts. II. The toxic effects of cytosine arabinoside on 125IUdR-labelled human leukaemic myeloblasts in mice.
    Sonis ST; Falcão R; MacLennan IC
    Br J Cancer; 1977 Sep; 36(3):307-12. PubMed ID: 270373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
    Pallavicini MG; Gray JW; Folstad LJ
    Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of cytosine arabinoside on unseparated bone marrow and peripheral blood cells and on specimens enriched for myeloblasts and promyelocytes.
    Epstein J; Preisler HD; Rustum YM; Higby DJ
    Exp Hematol; 1980 Apr; 8(4):404-8. PubMed ID: 7461048
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.
    Cadman E; Eiferman F
    J Clin Invest; 1979 Sep; 64(3):788-97. PubMed ID: 288743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
    Karp JE; Burke PJ; Donehower RC
    Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ara-C differentially affects multiprotein forms of human cell DNA polymerase.
    Wills PW; Hickey R; Malkas L
    Cancer Chemother Pharmacol; 2000; 46(3):193-203. PubMed ID: 11021736
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW; Major PP; Munroe D; Egan M; Herrick D
    Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ARA-C incorporation on deoxyribonucleic acid synthesis in cells.
    Major PP; Egan EM; Herrick DJ; Kufe DW
    Biochem Pharmacol; 1982 Sep; 31(18):2937-40. PubMed ID: 7138584
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS; Chou TC; Andreeff M; Vale K; Clarkson BD; Young CW
    Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in culture.
    Fountzilas G; Inoue S; Ohnuma T
    Leukemia; 1990 May; 4(5):321-4. PubMed ID: 2388478
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A new sensitive method for determination of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate content in human materials in vivo.
    Yamauchi T; Ueda T; Nakamura T
    Cancer Res; 1996 Apr; 56(8):1800-4. PubMed ID: 8620496
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
    Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
    Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of synergistic cell killing by hydroxyurea and cytosine arabinoside.
    Tanaka M; Kimura K; Yoshida S
    Jpn J Cancer Res; 1985 Aug; 76(8):729-35. PubMed ID: 3930450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.